Stéphane Mazy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Stéphane Mazy has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Françoise Kayser
Departement of Radiology, CHU UCL Namur , Namur 5000
1 shared publication - Hadrien Fourneau
Department of Radiology, CHU UCL Namur/Site Godinne, Yvoir, Belgium
1 shared publication - Olivier C. Mazy
Department of Pharmacy, Faculty of Medicine Université de Namur (UNamur) Namur Belgium
1 shared publication
Latest Publications
- Open Access
- 18 August 2021
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 49 (9) , 984-986
Breast implant seroma: A SARS‐CoV‐2 mRNA vaccine side effect
Fluid collection surrounding breast implants, called seroma, is a frequent issue that has diverse etiologies. We describe a 48‐year‐old woman with an acute onset of bilateral breast swelling occurring 5 years after aesthetic surgery and 10 days after a second SARS‐CoV‐2 mRNA vaccine dose. At breast ultrasound, we found an abundant bilateral peri‐implant seroma. Our patient noticed symptom improvement 48 h after nonsteroidal anti‐inflammatory drug treatment, complete disappearance of symptoms after 10 days with seroma disappearance documented by ultrasound. We hypothesized a breast implant seroma as post‐SARS‐CoV‐2 mRNA vaccine side effect, as different other diagnosis had been excluded.
- 18 August 2021
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 49 (9) , 984-986
Open AccessBreast implant seroma: A SARS‐CoV‐2 mRNA vaccine side effect
Fluid collection surrounding breast implants, called seroma, is a frequent issue that has diverse etiologies. We describe a 48‐year‐old woman with an acute onset of bilateral breast swelling occurring 5 years after aesthetic surgery and 10 days after a second SARS‐CoV‐2 mRNA vaccine dose. At breast ultrasound, we found an abundant bilateral peri‐implant seroma. Our patient noticed symptom improvement 48 h after nonsteroidal anti‐inflammatory drug treatment, complete disappearance of symptoms after 10 days with seroma disappearance documented by ultrasound. We hypothesized a breast implant seroma as post‐SARS‐CoV‐2 mRNA vaccine side effect, as different other diagnosis had been excluded.